GlassScriptPhysician profile
Adam M Maciver
NPI 1821439779
$2,622.51
in general payments reported to CMS, 2019-2025
14 companies · $625 in 2025
The $625 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $661 · 2022: $589 · 2023: $350 · 2024: $398 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $510.56 | 2021-2024 | |
| Optinose US, INC. | $506.93 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $382.33 | 2021-2025 | Dupixent |
| Genzyme Corporation | $334.03 | 2021-2025 | |
| Harmony Biosciences LLC | $223.06 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $143.01 | 2023-2025 | Lumryz |
| Alk-Abello, INC | $124.04 | 2021-2024 | Standardized Mite D. Farinae, Timothy, Standardized, Ragwitek |
| Inspire Medical Systems, INC. | $109.73 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $107.86 | 2023 | Nucala |
| Aerin Medical INC. | $67.54 | 2025 | |
| Phadia US INC. | $43.84 | 2021-2023 | Immunocap |
| Stryker Corporation | $37.45 | 2022 | |
| Merck Sharp & Dohme LLC | $16.56 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Maciver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.